Format

Send to

Choose Destination
Mol Genet Metab. 2017 Mar;120(3):278-287. doi: 10.1016/j.ymgme.2016.11.004. Epub 2016 Dec 27.

Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN).

Author information

1
Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, USA; Department of Neurology, Oregon Health & Science University, Portland, USA.
2
Molecular Neurosciences, Developmental Neurosciences Programme, UCL Institute of Child Health, London, UK.
3
Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, USA.
4
Department of Physiatry, Children's Healthcare of Atlanta, GA, USA.
5
Department of Child Neurology, The Children's Memorial Health Institute, Warsaw, Poland.
6
NBIA Disorders Association, El Cajon, CA, USA.
7
Hoffunngsbaum e.V., Velbert, Germany.
8
AISNAF - Associazione Italiana Sindromi Neurodegenerative Da Accumulo Di Ferro, Rossano, Italy.
9
Science Compass, Milano, Italy.
10
Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
11
Department of Pediatric Neuroscience, IRCCS Foundation Neurological Institute C. Besta, Milan, Italy.
PMID:
28034613
DOI:
10.1016/j.ymgme.2016.11.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center